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Domiciliary nasal respiratory support 
- first experiences in Malta 
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ABSTRACT: Nasal respiratory support is a non-invasive alternative to conventional assisted 
ventilation with endotracheal intubation, or the more cumbersome negative pressure ventilators. 
The two main types of this relatively new therapy are nasal intermittent positive pressure 
ventilation [NIPPV] and nasal continuous positive airway pressure [NCPAP] respiratory support, 
which are mostly used in chronic hypoventilatory states and obstructive sleep apnoea [OSA] 
respectively. We have introduced these two types of respiratory support to five patients suffering 
from neuromuscular disorders and twenty-four patients with OSA with marked improvement in 
the quality of life of all patients concerned. Our experiences with these patients should hopefully 
lead to further development in the diagnostic and therapeutic facilities in this field in Malta. 
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Introduction 
Until recently, patients with ventilatory problems 
needing long-term artificial assisted ventilation, initially 
required endotracheal intubation and later a permanent 
tracheostomy or the cumbersome 'cuirass', Since the 
advent of nasal respiratory support, physicians can treat 
these patients without having to resort to such invasive 
measures, thereby improving the patient's quality of life 
markedly. 
Nasal intermittent poslt!ve pressure ventilation 
[NIPPV] and nasal continous positive airway pressure 
[NCPAP] are the two most widely used modes of this 
type of non-invasive respiratory support, and when used 
in the appropriate cases, can transform the patient's 
lifesty le in the short term 1.2 and improve the prognosis 
of his ventilatory condition together with its secondary 
effects, in the long term3.4. 
Nasal respiratory support has been used in Malta in the 
last two years and we have succeeded in starting a good 
number of patients on this type of treatment from which 
they are still benefiting today. 
The start of nasal respiratory support in Malta 
Up to two years ago the only Maltese patient utilising 
domiciliary NIPPV was a young girl suffering from 
Ondine's curse secondary to damage of her respiratory 
centre by severe pertussis infection. She had initially 
been treated in an 'iron lung' in the intensive care unit at 
St. Luke's Hospital, after unsuccessful attempts at 
weaning her off invasive ventilation. Following transfer 
to the UK, she was started on an NIPPV ventilator which 
she subsequently used every night because of nocturnal 
hypoventilation. She forms part of our series of patients 
described below. In November 1994 a fourteen year old 
male suffering from Duchenne muscular dystrophy, who 
was admitted to hospital 'in extremis' , was the first 
patient to be started on NIPPV at St. Luke's Hospital. 
He had been complaining of morning headaches for the 
weeks preceding admission and his parents had noted 
that he was becoming more drowsy and cyanosed as 
time went by. Ultimately he lapsed into unconsciousness 
on the day of admission when his arterial blood gases 
revealed a PaC02 of 94.2mm Hg and a Pa0 2 of 65mm 
Hg. Within two hours of commencing NIPPV he had 
regained consciousness and his arterial blood gases had 
improved markedly [PaC02 62mm Hg, Pa0 2 82mm Hg]. 
This young man is still alive today and is using NIPPV 
nightly to compensate for nocturnal hypoventilation and 
daytime hypoxia and hypercapnia. The success of 
these two cases prompted the application of nas-al 
respiratory support for other such patients and also for 
other indications. 
Nasal intermittent positive 
pressure ventilation [NIPPV] 
Nocturnal hypoventilation is the major indication for 
this type of ventilation in which the airway pressure 
changes phasically throughout the cycle, delivering the 
entire tidal volume and then allowing passive exhalation. 
NIPPV is thought to help these patients by resting 
fatigued muscle5, increasing lung compliance6, and 
restoring some of the blunted CO2 sensitivity of the 
respiratory centre 7. Like other types of nasal respiratory 
support, it is administered through a small ventilator/ 
blower which may either be volume or pressure­
dependent. The positive pressure is instituted through a 
tight-fitting nasal mask which forms a seal by being 
held to the face by an appropriate type of head-gear8 
(See Fig 1). This assembly transmits the pressure or 
volume generated by the ventilator to the airways. The 
development of silicone masks have made these much 
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I Fig . 1 - A patient with the nasal mask and head gear 
\ 
used in nasal support 
more comfortable while creating better seals. 
Improvements are being made continuously such as full 
face masks for patients who have mouth-leaks and small 
nasal cushion masks for those who find the bigger masks 
claustrophobic9. 
Nasal continuous positive 
airway pressure [NCPAP] 
With NCPAP positive airway pressure is maintained, 
relative to atmospheric pressure, throughout the cycle10. 
NCPAP was introduced by Dr. Colin Sullivan in 
Australia as a means of splinting the upper airways 
during sleep in patients with obstructive sleep apnoea 
[OSAP1. Nasal bi-Ievel positive airway pressure 
[NBIPAP] is a modification of NCPAP in that the 
positive pressure is decreased slightly during the 
expiratory phase of the cycle so as to make the whole 
process more comfortable for the patient thus, 
presumably, increasing the compliance rate. 
The commonest symptoms of obstructive sleep apnoea 
are excessive daytime somnolence and irregular pattern 
of snoring, which latter, in the majority of cases, is due 
to repeated collapse of the oropharyngeal musculature 
during sleep. This results in complete or partial 
obstruction of the subject's airway accompanied by a 
reduction in blood oxygen saturation and followed by 
waking to breathe. These repeated episodes lead to sleep 
fragmentation with the deeper stages of sleep [rapid eye 
movement stages] being the most affected. It should be 
distinguished from the much less common central sleep 
apnoea which is a neurological disturbance resulting in a 
cessation of respiratory effort in sleep. OSA has come to 
the medical forefront in the last few years as the 
commonest type of sleep-related breathing disorder. 
Many sufferers are unaware of the cause of their 
excessive daytime sleepiness and pathological tendency 
to fall asleep, sometimes even while driving their car, 
leading to fatal or near-fatal accidents 12. Their sleeping 
partner complains about their loud snoring interrupted by 
long breathing pauses and excessive body-movements. 
This often leads to marital disharmony, mental 
depressionl3, lack of libido and impotence 14. OSA 
adversely affects the quality of life of the subject and can 
decrease the life expectancy of a 50 year old sufferer by 
50%15. The effects of OSA on the cardiovascular 
system include life-threatening arrythmias 16, systemic 
hypertension 17 and myocardial ischaemia18 , while the 
recurrent hypoxic episodes can also lead to pulmonary 
vascular disorders l9. 
The diagnosis is made from a suggestive history and a 
sleep-study (polysomnogram) 20 in order to differentiate 
OSA from other sleep-related disorders and simple 
snoring 21.22. During polysomnography a number of the 
following parameters are monitored: electro­
encephalogram (EEG), electrocardiogram (ECG), ocular 
and genohyoid electromyogram (EMG), respiratory 
effort and air flow, oxygen saturation, apnoea/hypopnoea 
time and frequency, body position, limb activity and 
snoring23 . An important analysis is the apnoea index 
which is the number of breathing pauses lasting 10 
seconds or longer per hour of sleep. An apnoea index of 
more than 5 is considered pathological by some 
investigators but others feel that 10 - 15/hr is a more 
specific measure for diagnosis24. Oxygen desaturations 
of >4% of baseline during hypopnoeas (a reduction in 
airflow associated with a fall in oxygen saturation and an 
arousal from sleep)25 also points towards a diagnosis of 
OSA. Difficulties in defining the diagnosis26 may 
explain the differences in prevalence rates between 
studies but the range is between 0.5 - 5% of the 
population24.27 . 
This paper describes how we screened, diagnosed and 
treated the first Maltese patients with OSA and nocturnal 
hypoventilation using nasal ventilation. The future of 
this modality of treatment in Malta is then discussed. 
Method 
1) NIPPV 
Subjects 
Since 1994, four patients suffering from 
neuromuscular conditions with secondary nocturnal 
hypoventilation were started on NIPPY. Three presented 
in acute Type 11 respiratory failure. A young girl was 
started on NIPPY for Ondine's curse following severe 
pertussis affecting her respiratory centre, and continued 
to be followed up. (Table 1) 
Ventilators 
A bulky Bromptonpac ventilator (Pneumopac Ltd., 
Luton) was initially used on two of these patients and 
later changed to a pressure-dependent NIPPY ventilator 
Thomas Respiratory Systems UK) weighing around 5 
kgs. Two of the other patients are al so on such a 
ventilator and all these four patients have had their 
inspiratory pressures set at around 10 cms H20 . 
Table I - Patients on NIPPY 
Subject Sex Age (yrs) Condition leading to res. failure 
I F 16 Central Res. Hypoventilation 
2 M 14 Duchenne Muscular Dystrophy 
3 F 42 Limb-Girdle Muscular Dystrophy 
4 F 37 Limb-Girdle Muscular Dystrophy 
5 M 17 Duchenne Muscular Dystrophy 
l 
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2) NCPAP 
Subjects 
Twenty-four patients (21 male and 3 female) with a 
mean age +/- SEM 43.4 +/- 2.9 yrs (range 19 - 66 yrs) 
all suffering from obstructive sleep apnoea were treated 
on NCPAP. All had a neck size of more than 17 inches 
in circumference (range 17 - 19.5 inches). Most were 
above the ideal weight for their height except two, who 
had an element of micrognatia. They all came from 
different walks of life but the majority (14 out of 24) 
were of professional or executive status. 
Diagnosis of obstructive sleep apnoea 
These twenty-four patients were diagnosed using a 
combination of history, clinical examination, blood 
investigations and a partial sleep study. 
History 
The help of the patient's sleeping partner was sought 
in taking a history where we specifically enquired about 
cardinal features such as excessive snoring with 
apnoeaic spells, nocturnal choking sensation, nocturia, 
reduced libido, morning headaches, increased limb 
movement in sleep, lack of daytime concentration and 
general well-being. A modification of the Epworth 
sleepiness scale28 was used to try and grade the patients' 
daytime sleepiness in specific situations such as when 
driving, reading, watching TV or talking to someone. 
Seventeen of the patients were asked to put a score of 1 
to 10 on a number of these symptoms before and after 
starting to use NCP AP so that we could grade any 
improvement the patient might experience. Enquiry was 
also made about alcohol or sedative ingestion, smoking, 
sleep hygiene, shift work, attempted weight reduction, 
nasal blockage and symptoms suggestive of 
hypothyroidism. 
Clinical examination 
During the clinical examination emphasis was put on 
nasal patency, the state of their soft palate and uvula, 
presence of micrognatia, neck size, blood pressure and 
any clinical signs suggestive of hypothyroidism and 
acromegaly. 
Blood investigations 
Apart from the routine blood tests the patients were 
screened for hypothyroidism and acromegaly in cases 
where these conditions were suspected. 
Partial sleep studies 
These studies were carried out at the coronary care 
unit at St. Luke's Hospital, when a monitor bed was 
available for the night in question. Using these 
monitors, continous percutaneous oxygen saturation, 
ECG, blood pressure, respiratory rate and apnoea 
frequency were studied. The nurses on night duty and 
one of the investigators (SM) observed the patient from 
time to time during the night to try and observe the 
snoring pattern, apnoeas, limb movements and body 
position during these events. In all we screened 38 
patients, 24 of which met most of the criteria we could 
monitor for OSA. When possible or in cases where the 
initial study revealed heart rhythm problems, we carried 
out another study during the first night on the machine. 
NCPAP machines 
In order to try and maximise the compliance rate we 
opted to use NBIPAP on most of the patients so as to 
make this treatment as comfortable as possible. In fact 
11 of our patients are on Respironics BIPAPS machines 
with the pressures used ranging between 10 - 18 cms 
H20 for the inspiratory positive airway pressure and 5 ­
14 cms H20 for the expiratory positive airway pressure. 
The machine was set on spontaneous mode so that the 
patient would trigger off the machine and not encounter 
undue resistance on expiration. Once adequate 
experience had been gained, it was decided to start the 
next patients on NCPAP (a mix of Respironics Remstar, 
DeYilbiss, Healthdyne and ResMed machines), which 
proved to be sufficient for the rest of the patients and 
considerably less expensive than the NBIPAP machines. 
Statistical analysis 
The symptom scores before and after NCPAP were 
compared using the Wilcoxon paired rank test. A p 
value of <0.05 was taken to represent a significant 
association or difference. 
Results 
NIPPV 
All five patients have noted a very marked subjective 
improvement in their quality of life since initiation of 
treatment and this was confirmed by their relatives. One 
of the young men is back attending school while another 
is now much more responsive and in good spirits than 
before treatment. The latter initially had some difficulty 
with increased oral secretions on using the ventilator but 
this has decreased since being started on inhaled 
Ipratropium Bromide 2 inhalations nocte through a 
spacer device. He is now also having some swallowing 
difficulties which are probably secondary to his 
muscular dystrophy. In the past, these patients would 
have succumbed to chest problems before encountering 
these difficulties. Similar improvement was noted in the 
other two female patients, both of which have returned to 
their jobs. All these patients are very compliant with 
treatment and are on the ventilator for at least six hours 
every night. Some even use it when experiencing 
problems in breathing during the day. At first some, 
especially the younger ones, felt claustrophobic with the 
nasal mask, but soon, all got used to it. 
The girl with the Ondine's curse was recently sent to 
the UK for a full sleep study and told that she could now 
stop using the NIPPY on a regular basis. 
NCPAP 
Of the 38 patients screened, 24 had enough evidence 
for a diagnosis of OSA. None of the patients screened 
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had any endocrine or major nasal problem to explain 
their complaints, while those who imbibed alcohol with 
their evening meal (four) or used sleeping-pills (three) 
stopped doing so. These measures, however, did not 
improve their sleep-related breathing disorder. All the 
overweight subjects had tried to lose weight but only two 
managed to lose a substantial amount and even these did 
not improve enough to render treatment with nasal 
CPAP unnecessary. There was no great difference in the 
sleepiness scale between the patients who ended up on 
nasal respiratory support and those who did not. 
However there was a marked difference before and after 
starting nasal ventilation in how sleepy the patient felt 
during the day (mean score before vs mean score after) 
(7.8 vs 1.6) and during driving (6.9 vs 0) (Fig 2). This 
improvement was also noted for nocturnal choking 
sensation (4.4 vs 0), concentration (5.1 vs 8.2) and 
general well-being (4.2 vs 8.8). The snoring in the 
treated group was noted to be as loud as in the group 
who were subsequently labelled as simple snorers. 
However, the snoring was more irregular, reached a 
crescendo more often and was interspersed with apnoeic 
spells. Much to the relief and appreciation of the 
patients' sleeping partners the patients on nasal NCPAP 
stopped snoring almost completely (9.3 vs 0.5). All 
these changes reached statistical significance (p<0.05). 
These symptom scores were not carried out by our seven 
most recent patients as it was too early to grade any 
improvement in concentration and well-being but they 
too improved in the rest of the symptoms. 
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Fig, 2 - Histogram showing patient scores for various 
obstructive sleep apnoea symptoms before and 
after NCPAP 
The partial sleep studies which were considered 
positive showed repeated oxygen desaturations which 
had to be at least 4% of baseline to be considered 
significant. In some cases these oxygen saturations 
dipped down even to the level of 55%. Four of our 
patients developed very worrying arrythmias (one had 
episodes of complete heart block, another had pauses of 
severe bradycardia (Fig 3) and the other two had runs of 
fast atrial fibrillation together with multiple ventricular 
ectopics) during some of the oxygen desaturations. 
Before inserting permanent pacemakers, it was decided 
to start nasal respiratory support urgently and this 
corrected the arrythmias together with the oxygen 
desaturations in the two patients with bradyarrythmias. 
The other two patients, who happen to be two of our 
recently treated patients, had fewer runs of atrial 
fibrillation than before during their first night on 
NCPAP. It is planned to repeat their sleep study in a few 
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Fig. 3 - Nocturnal oximetry and ECG readings in a 
patient suffering from OSA 
a) before NCPAP showing desaturations and arrythmia 
b) while on NCPAP showing correction of abnormal 
parameters 
weeks time to see whether the arrythmogenicity of their 
myocardium will have decreased following the use of 
NCP AP for this period of time. 
The patients on whom NCPAP or NBIPAP was 
instituted, were all admitted to hospital for their first 
night on the ventilator. All but two accepted the nasal 
mask very well. One of these two patients who 
continued to find difficulties was given a nasal bubble­
cushion mask (Monarch mask; Respironics, USA) and 
has adapted to this very well. The other patient has 
decided to postpone regular use of NCP AP for some 
time. Once he decides to initiate treatment we plan to 
use the Monarch mask again so as to increase the 
chances of acceptance. The pressure settings of the 
machine were adjusted according to the build of the 
patient29 as we did not have the facility to titrate airway 
pressures in our partial sleep studies. During this first 
night we decreased the pressures gradually till the patient 
either started snoring or breathing irregularly and then 
increased again to just above the breakthrough pressure 
level. All the patients, without exception, commented 
favourably about how much better they felt on waking 
up after that first night and their subjective improvement 
continued to increase over the first few nights. 
Subsequent improvement decreased when patients 
defaulted treatment for as little as 2-3 nights. The most 
common complaints were airway dryness, nasal bridge 
soreness and facial marks from the mask, breathing 
warm air on hot nights and the aesthetics of the whole 
process. 
Discussion 
In this paper we have demonstrated the introduction of 
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a novel mode of treatment for patients with nocturnal 
hypoventilation secondary to neuromuscular conditions 
and for OSA sufferers in Malta. Nasal respiratory 
support has improved the quality of life in all these 
patients, indeed for three patients with neuromuscular 
disease, this proved to be life-saving. This improvement 
in quality of life is the short term result of the 
treatment2.30. The long term benefits which have been 
shown to occur in major studies, will hopefully be 
experienced by our patients as well. 
In the past, most patients suffering from muscular 
......, 	 dystrophy, would die prematurely from respiratory 
problems - usually due to acute or acute on chronic 
respiratory failure precipitated by a chest infection. 
Preceding this, these patients usually develop cor 
pulmonale from hypoventilation due to their muscular 
weakness and thoracic skeletal malformations. Now, 
these acute and chronic chest problems can all be helped 
by NIPPV as demonstrated in this series of patients. 
Similar patients presenting in acute respiratory failure 
usually present a difficult dilemma to the admitting 
physician as whether to intubate and ventilate, knowing 
that their chances of being weaned off are slim31 . 
Despite a poor prognosis, these patients would occupy a 
precious ITU bed for a long time. Nasal ventilation 
offers a useful alternative to full ventilatory support. 
Indeed, this was successful in the three acute situations 
encountered. In the chronic situation, all these patients 
felt better during their waking hours as their hypercapnic 
and hypoxic state was an1eliorated. 
NIPPV can also be used in other cases of chronic 
respiratory failure such as mUltiple sclerosis, central 
hypoventilation syndrome, motor neurone disease and 
chest wall deformities, but its use in chronic obstructive 
airway disease is still controversial32 . The current 
position is that NIPPV seems to benefit only those cases 
of COAD who have high daytime P aC02 (>56mmHg)33 
and may also be considered in acute exacerbations34 in 
patients who either refuse intubation or who would not 
otherwise be considered ideal for endotracheal intubation 
and ventilation. 
NCPAP and NBIPAP, the other mode of nasal 
respiratory support utilised in this series of patients, also 
proved to be of major benefit to the patients involved. 
OSA is a debilitating condition with implications and 
negative effects on the patient'S personal, social, 
professional and physical lifestyle. Again the long-term 
effects of this condition can also lead to an untimely 
death due to cardiac arrythmias and ischaemia together 
with the complications encountered in chronic 
respiratory failure and systemic hypertension 16.18. The 
real life caricature of an overweight man who dozes off 
easily and snores loudly presents a serious medical 
problem. OSA is little known anlOng lay people and 
doctors alike, and must be 'publicised' so as to be 
recognised and treated more often. The number of 
patients presenting to us is now increasing partly as a 
result of the positive feedback from successfully treated 
patients. Our patients have all experienced a great 
improvement in their quality of life and this, in turn, is 
improving their compliance to treatment. 
The fact that accidents such as motor-vehicle 
collisions can affect third parties, makes the situation 
even more worrisome. The condition is much more 
common than one expects with 2 - 4% of the American 
population thought to suffer from various grades of 
OSA24. The fact that the average Maltese person is 
rather overweight makes it likely that the prevalance of 
OSA in our country is at least just as high. 
Great changes are being made in the field of 
development of NCPAP machines as these ventilators 
are now becoming more 'user-friendly', comfortable. 
lighter and thus more portable. Features such as 
ramping, which allows a slow build-up of pressure after 
sleep onset, demand CPAP and AutoCP AP in which the 
machine senses when the patient does not require CPAP 
and switches off, have become available in the last 
couple of years. All these are designed to increase 
patient compliance35 . Options such as drastic surgery36 
as in uvulopalatopharyngoplasty (UVPP)37 have not 
been very successful, while newer laser surgery is still 
unproven. Other studies have looked at tracheostomies 
and oral appliances38 but these are not very popular. In 
children, where sleep apnoea is also encountered. 
surgery in the form of adenoidotonsillectomy tends to 
correct the majority of OSA cases39. NCPAP is only 
required In children with craniofacial anomalies. 
trisomy21 and skeletal dysplasia syndromes, who have 
not responded fully to surgery40. 
In our opinion, the setting up of a sleep laboratory is 
badly needed at our hospital as evidenced by the above 
results. The condition is common and treatable. but the 
current facilities are not sensitive or specific enough for 
us to be sure that we are detecting all cases of OSA 
anlOngst the patients we screen. At the present time we 
are only able to monitor few of the criteria required for a 
diagnosis and even these are not being sampled 
frequently enough41. We are also currently unable to 
titrate NCPAP pressures and have to use a rather crude 
method to decide pressure settings for different patients. 
The institution of a sleep laboratory does not entail alot 
of expense apart from the initial expenditure and the 
training of a sleep technician. If space is a problem there 
are new polysomnograms available on the market which 
the patient can take home with him for monitoring in his 
usual nocturnal surroundings42. Another facility that 
would obviously be required is a sleep clinic where these 
patients would be seen. screened and followed up. Such 
a clinic would also be able to carry out research and try 
these modes of therapy for new indications such as acute 
left ventricular failure43 . 
In conclusion we have reviewed the first series of 
patients which has been initiated on respiratory support 
for different conditions in Malta. We have discussed the 
positive impact of this treatment on these patients and 
their condition and demonstrated that this is a field 
which is worth pursuing. The development of 
domiciliary respiratory support can offer significant 
benefits to patients with respiratory insufficiency and 
should be pursued by clinicians and the Health Division. 
alike. 
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